Latest Amides Stories
Initiation of Registrational Studies Planned for This Year MORRISTOWN, N.J., Jan.
Reaction Times Outshine Those Where No Hydration Was Given* New York, NY (PRWEB) January 15, 2015 Taking Kyowa Hakko USA's Sustamine® L-Alanyl-L-Glutamine
MUMBAI and BALTIMORE, January 6, 2015 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
ReportsnReports.com adds “Seborrhea - Pipeline Review, H2 2014” to its store.
BUFFALO, N.Y., Dec.
WILMINGTON, Del., Dec. 19, 2014 /PRNewswire/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZA(TM) (olaparib) capsules.
SAN DIEGO, Dec.
Follow-up data from the Phase 2 PCYC-1104 trial presented at the American Society of Hematology Annual Meeting show sustained efficacy and safety over time SAN FRANCISCO and RARITAN, N.J.,
- Phase I study results presented at American Society of Hematology Annual Meeting RIDGEFIELD, Conn., Dec. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
-- Results of Investigational Studies of Perampanel and Rufinamide Accepted as Late-Breaking Posters -- WOODCLIFF LAKE, N.J., Dec. 5, 2014 /PRNewswire/ -- Eisai Inc.
- A poem in which the author retracts something said in an earlier poem.